Stocks / Medical Devices
BSXMedical Devices
Boston Scientific Corp.
$43.531d -1.2%5d +0.6%settled close · 2026-09-17
Mkt cap $101B (3/25)β 0.0452w $43–105Shares 1.49BInd. Surgical & Medical Instruments & ApparatusNYSE since 1992Emp. 59,000HQ Marlborough, MAbostonscientific.com
The tape, with the calls on it
Who said what, and what BSX did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
bullish
bearish
both sides
Who’s talkingIdea Scout · free
Who’s talking about BSX
1 longlatest 2025-01-18
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2025-01-18 | David MandelbaumPortfolio Manager, OnePoint BFG | Bullish | Wealthion | Medical technology companies like Boston Scientific are among his two most exciting opportunities because… |
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 28 Oct 2026 before the open
Confirmed date · consensus EPS 0.79. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where BSX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 10 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-10 | ||||||
| 2026-09-01 | ||||||
| 2026-07-29 | ||||||
| 2026-07-28 | ||||||
| 2026-07-16 | ||||||
| 2026-07-02 | ||||||
| 2026-05-28 | ||||||
| 2026-05-27 | ||||||
| 2026-04-01 | ||||||
| 2026-03-30 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
BSX is in this morning’s Brief.
Get The Brief — $20/mo →